A Review of Analytical Methods for the Determination of Tibolone: Pharmacokinetics and Pharmaceutical Formulations Analysis and Application in Doping Control-Reference-Cited by-同舟云学术

A Review of Analytical Methods for the Determination of Tibolone: Pharmacokinetics and Pharmaceutical Formulations Analysis and Application in Doping Control

Published:2020-11-23 Issue:1 Volume:17 Page:31-39
ISSN:1573-4129
Container-title:Current Pharmaceutical Analysis
language:en
Short-container-title:CPA

Author:

Ângelo Marilene Lopes¹^ORCID,de Lima Moreira Fernanda²^ORCID,Araújo Santos Ana Laura³^ORCID,Nunes Salgado Hérida Regina⁴^ORCID,de Araújo Magali Benjamim¹^ORCID

Affiliation:

1. Faculty of Pharmaceutical Sciences, Federal University of Alfenas, 700, Rua Gabriel Monteiro da Silva, 37130-000, Alfenas, MG, Brazil

2. School of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo, 14040-903, Ribeirao Preto, SP, Brazil

3. School of Biological Sciences - Bangor University, Deiniol Road, LL57 2UW, Bangor, Brazil

4. Faculty of Pharmaceutical Sciences, UNESP, Campus Araraquara, Rodovia Araraquara Jau, km 01, 14800-903, Araraquara, SP, Brazil

Abstract

Background: Tibolone is a synthetic steroid commercialized by Organon under the brand name Livial (Org OD14), which is used in hormone therapy for menopause management and treatment of postmenopausal osteoporosis. Tibolone is defined as a selective tissue estrogenic activity regulator (STEAR) demonstrating tissue-specific effects on several organs such as brain, breast, urogenital tract, endometrium, bone and cardiovascular system. Aims: This work aims to (1) present an overview of important published literature on existing methods for the analysis of tibolone and/or its metabolites in pharmaceutical formulations and biological fluids and (2) to conduct a critical comparison of the analytical methods used in doping control, pharmacokinetics and pharmaceutical formulations analysis of tibolone and its metabolites. Results and conclusions: The major analytical method described for the analysis of tibolone in pharmaceutical formulations is High Pressure Liquid Chromatography (HPLC) coupled with ultraviolet (UV) detection, while Liquid Chromatography (LC) or Gas Chromatography (GC) used in combination with Mass Spectrometry (MS) or tandem mass spectrometry (MS/MS) is employed for the analysis of tibolone and/or its metabolites in biological fluids.

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmaceutical Science,Molecular Medicine,Biochemistry,Biophysics

Reference68 articles.

1. Dennerstein L.; Dudley E.C.; Hopper J.L.; Guthrie J.R.; Burger H.G.; A prospective population-based study of menopausal symptoms. Obstet Gynecol 2000,96(3),351-358

2. Sherman S.; Defining the menopausal transition. Am J Med 2005,118(Suppl. 12B),3-7

3. Cohen L.S.; Soares C.N.; Vitonis A.F.; Otto M.W.; Harlow B.L.; Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Arch Gen Psychiatry 2006,63(4),385-390

4. ACOG Practice Bulletin No 141: management of menopausal symptoms. Obstet Gynecol 2014,123(1),202-216

5. NIH State-of-the-Science Conference Statement on manifestations and management of chronic insomnia in adults. NIH Consens State Sci Statements 2005,22(2),1-30